SurvivorNet on MSN
New drug combination shows promise in advanced colorectal cancer: The question now is when to use it
A two-drug combination (zanzalintinib plus atezolizumab) improved survival for metastatic colon cancer patients who already ...
UAB Medicine offers liver transplantation as a treatment for metastatic colorectal cancer, expanding access to advanced ...
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic ...
Deep Creek Pharma has secured a boost in funding as the company nears Phase I clinical trials for its next-generation ...
The prognostic factors for refractory metastatic colorectal cancer treated with trifluridine–tipiracil. MSI-H : Microsatellite instability High. dMMR : Mismatch repair deficient. RCT : Randomised ...
Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study. Efficacy and safety of ...
A general surgeon talks with a patient about a colon cancer screening. (File photo courtesy of the U.S. Navy) San Diego-based biotechnology company Cardiff Oncology has reported positive data from a ...
The quantification issues related to comparisons of matched primary tumors and metastases assessed using CGH, fluorescence in situ hybridization (FISH), and mutation analyses are more straightforward.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results